16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      How Support of Early Career Researchers Can Reset Science in the Post-COVID19 World

      news

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The COVID19 crisis has magnified the issues plaguing academic science, but it has also provided the scientific establishment with an unprecedented opportunity to reset. Shoring up the foundation of academic science will require a concerted effort between funding agencies, universities, and the public to rethink how we support scientists, with a special emphasis on early career researchers.

          Abstract

          The COVID19 crisis has magnified the issues plaguing academic science, but it has also provided the scientific establishment with an unprecedented opportunity to reset. Shoring up the foundation of academic science will require a concerted effort between funding agencies, universities, and the public to rethink how we support scientists, with a special emphasis on early career researchers.

          Related collections

          Most cited references7

          • Record: found
          • Abstract: not found
          • Article: not found

          Opinion: In the wake of COVID-19, academia needs new solutions to ensure gender equity

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Gender Equality in Academia: Bad News from the Trenches, and Some Possible Solutions

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A generation at risk: young investigators and the future of the biomedical workforce.

              A number of distressing trends, including a decline in the share of key research grants going to younger scientists, as well as a steady rise in the age at which investigators receive their first funding, are now a decades-long feature of the US biomedical research workforce. Working committees have proposed recommendations, policy makers have implemented reforms, and yet the trajectory of our funding regime away from young scientists has only worsened. An investigation of some of the major factors and their geneses at play in explaining the increasing average age to first RO1 is presented. Recommendations related to funding, peer review, career paths, and the university-government partnership are provided.
                Bookmark

                Author and article information

                Contributors
                Journal
                Cell
                Cell
                Cell
                Elsevier Inc.
                0092-8674
                1097-4172
                12 June 2020
                12 June 2020
                Affiliations
                [1 ]Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA 94305, USA
                [2 ]Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
                [3 ]Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA 94305, USA
                [4 ]Department of Biology, University of Virginia, Charlottesville, VA 22903, USA
                [5 ]Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110, USA
                [6 ]Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, CA 94305, USA
                [7 ]The Salk Institute for Biological Studies, La Jolla, CA 92037, USA
                [8 ]Neuroscience Institute, NYU School of Medicine, New York, NY 10016, USA
                [9 ]Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA
                [10 ]Departments of Neuroscience and Genetics, Washington University School of Medicine, St. Louis, MO 63110, USA
                [11 ]Department of Pathology, Section on Comparative Medicine, Wake Forest School of Medicine, Winston-Salem, NC 27517, USA
                Author notes
                []Corresponding author egibson1@ 123456stanford.edu
                [12]

                Lead Contact

                Article
                S0092-8674(20)30678-4
                10.1016/j.cell.2020.05.045
                7291965
                a08d1874-5889-4d3b-826b-7e20bb11634c
                © 2020 Elsevier Inc.

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                Categories
                Article

                Cell biology
                Cell biology

                Comments

                Comment on this article